Connect Has A Best-In-Class Anti-IL-13 In Eczema, But Won’t Be Taking On Apogee Yet Citeline News & Insights Source link
Expectations For Sanofi’s Dupixent Successor Drop On Latest Eczema Data Citeline News & Insights Source link
Expert Insights on Personalizing Atopic Dermatitis Treatment Dermatology Times Source link
“Don’t Touch This”: Contact Dermatitis Insights and Updates from Matthew Zirwas, MD Dermatology Times Source link